• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT SECTIONS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • VIDEOS

150 U.S. Patients Treated in each of the One and Two-Level IDE Clinical Trials of the Spineart BAGUERA® C Cervical Disc Prosthesis

December 13, 2022 By SPINEMarketGroup

LAGUNA HILLS, CA, December 13th, 2022 – Spineart USA Inc. announced today that surgery has been performed on 150 patients in both the one and two-level for a total of over 300 patients to date in the U.S. Investigational Device Exemption (IDE) Clinical Trials of the BAGUERA® C Cervical Disc Prosthesis. The BAGUERA® C implant is an investigational device in the U.S. designed to reconstruct the cervical disc following discectomy for symptomatic cervical disc disease.

Just over one year after the start of the two studies in more than 25 sites, this milestone surpasses our enrollment midpoint.

“It’s exciting to have both arms, 1- and 2-level, of the BAGUERA® C study reach this significant enrollment milestone. It’s one step closer to making this innovative cervical artificial disc available to patients in the US.” said Dr Dom Coric, of the Jerry and Audrey Petty Endowed Professor of Spine Surgery at Atrium Health (NC) and one of the lead Principal Investigators on the studies.

“I would like to acknowledge our surgeon clinical investigators, their research, clinical and surgical teams and the Spineart team for their relentless efforts and this wonderful milestone after this first full year of enrollment. We are witnessing a growing interest throughout the U.S. for artificial cervical disc replacement as an alternative to fusion for the adequate candidates. We look forward to completing enrollment of both studies and contribute the clinical data to the growing body of level II evidence supporting cervical arthroplasty” said Jerome Trividic, CEO of Spineart.

Surgery to treat cervical degenerative disc disease is generally considered when neurological symptoms are present, such as persistent arm numbness and/or weakness, or when chronic pain is severe and not adequately relieved after at least six months of non-surgical treatments, and daily activities become difficult. Artificial cervical disc replacement involves the removal of the problematic disc and replaces it with an artificial prosthesis. The goal of this surgery is to restore the height and preserve motion at that spinal level.

About the BAGUERA® C Cervical Disc Prosthesis

The BAGUERA® C Cervical Disc Prosthesis, developed by Spineart SA (Geneva, Switzerland), is an investigational device in the U.S. designed to maintain or restore segmental motion and disc height in the cervical region of the spine following single- or two-level discectomy for symptomatic cervical disc disease. The BAGUERA® C is designed to maintain the natural behavior of a functional spinal unit. This design enables the BAGUERA® C nucleus to move in all six degrees of freedom, with independent angular rotations (flexion-extension, lateral bending, and axial rotation) along with independent translational motions (anterior-posterior and lateral translations).

To find a clinical study site near you, or to learn more about the IDE, visit: https://www.spineart.com/us/ide-clinical-investigation/
CAUTION—Investigational device. Limited by United States law to investigational use.

(Visited 129 times, 8 visits today)

Filed Under: NEWS Tagged With: 2022, NEWS

Primary Sidebar

PLATINUM SPONSORS

GOLD SPONSORS

MOST POPULAR POSTS

  • BROCHURES
  • Stryker’s Spine Business Sale: A Smart Move or a…
  • Stryker’s Spine Exit: What It Means for…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • (UPDATED 2024): +8 Lumbar Artificial Discs to Know…
  • What Are the Strategic Reasons Behind Globus…
  • Why Didn’t Globus Medical’s Stock Rise After…
  • Update:Stay Tuned Next Week! Is Globus Medical the…
  • Globus Medical extends versatility of Advanced…
  • M6 Discontinued: What Are the Alternatives for a…
  • Dispute Over Spinal Implant Royalties Between…
  • (Updated!) 15 Expandable PLIF Cages to Know…!
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • Alphatec Today: Where It Stands and Where It’s Heading?
  • (UPDATED 2024): +108 Stand-Alone Cervical Cages to Know..!
  • Eminent Spine’s 3D Printed Titanium Pedicle Screw…
  • Has Globus Already Surpassed Medtronic in the Spine…
  • What’s Happening with Globus Medical? Why Has the…
  • Johnson & Johnson MedTech Secures Exclusive…
  • Sunday Reflections on the Changes in the Spine Market!
  • LAST 10 VIDEOS PUBLISHED

    1. POWEHI MEDICAL AG: TANTO® Screw
    2. Syntropiq: Taurus TLIF (Short)
    3. LEM Surgical: Dynamis Surgical Robot
    4. Aegis Spine:PathLoc-TA
    5. NGMedical: MOVE®-C Artificial Disc
    6. B.Braun Aesculap: Ennovate® Cervical MIS
    7. Spineart: PERLA® TL Deformity Solutions
    8. NGMedical: MOVE®-C
    9. Normmed Medical: ALIF Peek Cage
    10. PainTEQ: LinQ Sacroiliac

    Recent Comments

    • SPINEMarketGroup on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Sergio López-Fombona on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Drew on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Ahmed Hassan El-Naggary on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Anonymous on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Mid-career Xennnial on Is Being a Doctor a Job, or a Calling? The Generational Divide Reshaping Medicine
    • Email
    • Twitter
    • YouTube

    Subscribe to Our Newsletter!

    Check your inbox or spam folder to confirm your subscription.

    Footer

    • Email
    • Twitter
    • YouTube

    Contact us:

    [email protected] [email protected]

    PRIVATE POLICY

    • Legal Advice
    • Embed Link
    • VIDEOS

    Copyright © 2025 · SPINEMarketGroup

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    View preferences
    {title} {title} {title}